Antimicrobial Susceptibility at UCSF Benioff Children's Hospital San Francisco

These reports are aggregated from clinical isolates submitted to the UCSF clinical microbiology laboratory from patients at the UCSF Benioff Children's Hospital San Francisco campus and are meant to guide clinicians in selecting empiric therapy.  Patient characteristics must be incorporated in determining risks and therapy should be modified based on susceptibility testing results when available. Breakpoints for susceptibility are via CLSI guidelines.

These reports are aggregated from clinical isolates submitted to the UCSF clinical microbiology laboratory from patients at the UCSF Benioff Children's Hospital San Francisco campus and are meant to guide clinicians in selecting empiric therapy.  Patient characteristics must be incorporated in determining risks and therapy should be modified based on susceptibility testing results when available. Breakpoints for susceptibility are via CLSI guidelines. Annual updates will reflect data from the previous calendar year, except as noted for portions of this report that will be updated every 3 years. This page was last updated 6/4/20. 

Methodology Notes

2019 Susceptibility Data

Inpatient and Emergency Department

Gram-Negative Organisms

     Report by Organism and Drug

     Incidence-Weighted Gram-negative Coverage by Drug

     Pseudomonas Coverage by Location and Drug(s)

Gram-Positive Organisms

     Report by Organism and Drug

     Vancomycin Minimum Inhibitory Concentrations Among Staphylococcus aureus

     Enterococcal Isolate Susceptibilities

Outpatients

Gram-Negative Organisms

     E. coli Susceptibilities

Gram-Positive Organisms

    Staphylococcus aureus Susceptibilities